Founded by Canva alumni, the precision health platform will use the funds to accelerate the firm’s UK expansion, expand its platform and scale research partnerships.
Patient-first precision health platform Human Health has raised £4.1 million in seed funding to accelerate the firm’s UK expansion, expand its platform and scale research partnerships as it builds its Precision Health OS, a platform designed for people navigating chronic conditions.
Founded by former product leaders of graphic design platform Canva, the round was led by LocalGlobe, Airtree and Skip Capital. Notable angels also participated, including Arvind Rajan (Cricket Health), Eric Salama (former Kantar CEO) and David Shein (GP at OIF Ventures).
Human Health describes itself as creating solutions that drive innovation centred on patients, not providers. Its platform creates a feedback loop where patients can track their health, surface hidden patterns, and generate useful insights.
“Our mission is simple: to give everyone access to personalised healthcare,” said co-founder Kate Lambridis.
“Right now, too many people are left in limbo; stuck on waiting lists, repeating their stories to different doctors, and trying to make sense of complex conditions without the right tools. Human Health is designed to change that,” she continued.
A unified health story
Human Health helps patients unify their health story. It securely captures history, symptoms, and treatments. Not only does the software track what matters, it detects hidden patterns by using AI to pick up correlations across mind, body and lifestyle. At the same time, it can be personalised by any focus area such as mental health, pain, gut, women’s health, autoimmune or sleep.
The firm boasts more than 200,000 patients worldwide who have tracked over 20 million health actions using the platform and are now logging over 40,000 health actions every day.
The new round of funding will accelerate the development of even more intelligent features, expand into new use cases, and give patients the option to contribute their anonymised experiences to research.
Human Health will also scale its B2B platform, Human Evidence, enabling select life sciences partners to gather real-world, patient-reported data for new studies.
“Our goal is to put patients at the centre of medicine itself, at the centre of their own care, and at the centre of how we move medical research forward. By connecting lived experience with real-world data, we can build a healthcare system that learns from patients, not just treats them,” said co-founder Georgia Vidler.
The firm has previously raised $A10.2 million (£5.1 million) in two rounds of funding, according to Crunchbase.
